Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and more, suggest data Read more
GSK gets US FDA nod for Benlysta (Belimumab) to treat paediatric patients with active lupus nephritis Read more
GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries Read more